In vitro and in vivo properties of distinct populations of amniotic fluid mesenchymal progenitor cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 9, 2011, Pages 1896-1913

  Roubelakis, Maria G ^a,b   Bitsika, Vasiliki ^a,b   Zagoura, Dimitra ^a,b   Trohatou, Ourania ^a,b   Pappa, Kalliopi I ^b   Makridakis, Manousos ^a   Antsaklis, Aristidis ^b   Vlahou, Antonia ^a   Anagnou, Nicholas P ^a,b  

^a BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Amniotic fluid; In vivo properties; Migration; MPCs; Proteomic analysis

Indexed keywords

ALPHA5 INTEGRIN; BIOLOGICAL MARKER; FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; NEUTRALIZING ANTIBODY; THY 1 ANTIGEN; TRANSCRIPTION FACTOR;

AMNION FLUID; ANIMAL; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; CELL SHAPE; CYTOLOGY; DRUG EFFECT; EMBRYONIC STEM CELL; GENETIC TRANSDUCTION; GENETICS; HUMAN; IMMUNOLOGY; LENTIVIRINAE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MOUSE; MOUSE MUTANT; PHENOTYPE; REPRODUCIBILITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMNIOTIC FLUID; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD44; ANTIGENS, THY-1; BIOLOGICAL MARKERS; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EMBRYONIC STEM CELLS; FIBRONECTINS; HUMANS; HYALURONIC ACID; INTEGRIN ALPHA5; LENTIVIRUS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; PHENOTYPE; REPRODUCIBILITY OF RESULTS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC;

MUS;

EID: 79958107746     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01180.x     Document Type: Article

References (53)

1. Smith JR, Pochampally R, Perry A, et al. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells. 2004; 22: 823-31.
2. Sekiya I, Larson BL, Smith JR, et al. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002; 20: 530-41.
3. Prockop DJ, Sekiya I, Colter DC. Isolation and characterization of rapidly self-renewing stem cells from cultures of human marrow stromal cells. Cytotherapy. 2001; 3: 393-6.
4. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci U S A. 2001; 98: 7841-5.
5. Lee RH, Hsu SC, Munoz J, et al. A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. Blood. 2006; 107: 2153-61.
6. Chang YJ, Tseng CP, Hsu LF, et al. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int. 2006; 30: 495-9.
7. Roubelakis MG, Pappa KI, Bitsika V, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 2007; 16: 931-52.
8. In 't Anker PS, Noort WA, Scherjon SA, et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica. 2003; 88: 845-52.
9. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007; 25: 100-6.
10. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102: 1548-9.
11. Tsai MS, Lee JL, Chang YJ, et al. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004; 19: 1450-6.
12. Tsai MS, Hwang SM, Tsai YL, et al. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod. 2006; 74: 545-51.
13. Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monit. 2002; 8: RA253-7.
14. Hoehn H, Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol. 1982; 26: 11-34.
15. Gosden CM. Amniotic fluid cell types and culture. Br Med Bull. 1983; 39: 348-54.
16. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18: 877-91.
17. Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitroexpansion, and characterization. Br J Haematol. 2003; 123: 702-11.
18. Zhu H, Mitsuhashi N, Klein A, et al. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells. 2006; 24: 928-35.
19. Yang MC, Chi NH, Chou NK, et al. The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin - Hyaluronic acid cardiac patches. Biomaterials. 2009; 31: 854-62.
20. Grisafi D, Piccoli M, Pozzobon M, et al. High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev. 2008; 17: 953-62.
21. Boker W, Yin Z, Drosse I, et al. Introducing a single-cell-derived human mesenchymal stem cell line expressing hTERT after lentiviral gene transfer. J Cell Mol Med. 2008; 12: 1347-59.
22. Meyerrose TE, Roberts M, Ohlemiller KK, et al. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells. 2008; 26: 1713-22.
23. Piersanti S, Sacchetti B, Funari A, et al. Lentiviral transduction of human postnatal skeletal (stromal, mesenchymal) stem cells:in vivotransplantation and gene silencing. Calcif Tissue Int. 2006; 78: 372-84.
24. Leschot NJ, Verjaal M, Treffers PE. Risks of midtrimester amniocentesis; assessment in 3000 pregnancies. Br J Obstet Gynaecol. 1985; 92: 804-7.
25. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol. 2006; 108: 1067-72.
26. Buhring HJ, Battula VL, Treml S, et al. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci. 2007; 1106: 262-71.
27. Zannettino AC, Roubelakis M, Welldon KJ, et al. Novel mesenchymal and haematopoietic cell isoforms of the SHP-2 docking receptor, PZR: identification, molecular cloning and effects on cell migration. Biochem J. 2003; 370: 537-49.
28. Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998; 72: 8463-71.
29. Siapati EK, Bigger BW, Miskin J, et al. Comparison of HIV- and EIAV-based vectors on their efficiency in transducing murine and human hematopoietic repopulating cells. Mol Ther. 2005; 12: 537-46.
30. Goodwin HS, Bicknese AR, Chien SN, et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 2001; 7: 581-8.
31. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
32. Jensen PK, Therkelsen AJ. Cultivation at low temperature as a measure to prevent contamination with fibroblasts in epithelial cultures from human skin. J Invest Dermatol. 1981; 77: 210-2.
33. Maier KG, Sadowitz B, Cullen S, et al. Thrombospondin-1-induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. Am J Surg. 2009; 198: 664-9.
34. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000; 24: 372-6.
35. Trosko JE. From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Ann N Y Acad Sci. 2006; 1089: 36-58.
36. Huang CH, Chen MH, Young TH, et al. Interactive effects of mechanical stretching and extracellular matrix proteins on initiating osteogenic differentiation of human mesenchymal stem cells. J Cell Biochem. 2009; 108: 1263-73.
37. Abramovici H, Mojtabaie P, Parks RJ, et al. Diacylglycerol kinase zeta regulates actin cytoskeleton reorganization through dissociation of Rac1 from RhoGDI. Mol Biol Cell. 2009; 20: 2049-59.
38. Ivakhno SS, Kornelyuk AI. Cytokine-like activities of some aminoacyl-tRNA synthetases and auxiliary p43 cofactor of aminoacylation reaction and their role in oncogenesis. Exp Oncol. 2004; 26: 250-5.
39. Tung JJ, Hobert O, Berryman M, et al. Chloride intracellular channel 4 is involved in endothelial proliferation and morphogenesisin vitro. Angiogenesis. 2009; 12: 209-20.
40. Davidson SM, Morange M. Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes. Dev Biol. 2000; 218: 146-60.
41. Park SH, Cho HN, Lee SJ, et al. Hsp25-induced radioresistance is associated with reduction of death by apoptosis: involvement of Bcl2 and the cell cycle. Radiat Res. 2000; 154: 421-8.
42. Anjos-Afonso F, Siapati EK, Bonnet D. In vivocontribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci. 2004; 117: 5655-64.
43. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
44. Colter DC, Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000; 97: 3213-8.
45. Rege TA, Hagood JS. Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006; 20: 1045-54.
46. Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells. 2008; 26: 300-11.
47. Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005; 23: 220-9.
48. Mostafavi-Pour Z, Askari JA, Parkinson SJ, et al. Integrin-specific signaling pathways controlling focal adhesion formation and cell migration. J Cell Biol. 2003; 161: 155-67.
49. Guillot PV, Gotherstrom C, Chan J, et al. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells. 2007; 25: 646-54.
50. Greco SJ, Liu K, Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells. 2007; 25: 3143-54.
51. Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004; 22: 625-34.
52. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109: 235-42.
53. Phipps RP, Penney DP, Keng P, et al. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol. 1989; 1: 65-74.